ATE66531T1 - Verfahren zum nachweis von immunkomplexen im serum. - Google Patents
Verfahren zum nachweis von immunkomplexen im serum.Info
- Publication number
- ATE66531T1 ATE66531T1 AT84904266T AT84904266T ATE66531T1 AT E66531 T1 ATE66531 T1 AT E66531T1 AT 84904266 T AT84904266 T AT 84904266T AT 84904266 T AT84904266 T AT 84904266T AT E66531 T1 ATE66531 T1 AT E66531T1
- Authority
- AT
- Austria
- Prior art keywords
- serum
- procedure
- detecting
- clq
- native
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/809—Multifield plates or multicontainer arrays
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/549,105 US4595654A (en) | 1983-11-07 | 1983-11-07 | Method for detecting immune complexes in serum |
EP84904266A EP0161306B1 (de) | 1983-11-07 | 1984-11-06 | Verfahren zum nachweis von immunkomplexen im serum |
PCT/US1984/001803 WO1985002261A1 (en) | 1983-11-07 | 1984-11-06 | Method for detecting immune complexes in serum |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE66531T1 true ATE66531T1 (de) | 1991-09-15 |
Family
ID=24191686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT84904266T ATE66531T1 (de) | 1983-11-07 | 1984-11-06 | Verfahren zum nachweis von immunkomplexen im serum. |
Country Status (12)
Country | Link |
---|---|
US (1) | US4595654A (de) |
EP (1) | EP0161306B1 (de) |
JP (2) | JPH0731195B2 (de) |
AT (1) | ATE66531T1 (de) |
AU (1) | AU575362B2 (de) |
CA (1) | CA1247539A (de) |
DE (1) | DE3484957D1 (de) |
DK (1) | DK309285D0 (de) |
IL (1) | IL73437A (de) |
IT (1) | IT1177121B (de) |
NO (1) | NO852705L (de) |
WO (1) | WO1985002261A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4595654A (en) * | 1983-11-07 | 1986-06-17 | Immunomedics Inc. | Method for detecting immune complexes in serum |
US4882423A (en) * | 1984-10-02 | 1989-11-21 | Calpis Food Industry | Substance-conjugated complement component C1q |
US5035995A (en) * | 1984-10-02 | 1991-07-30 | Calpis Food Industry Co., Ltd. | Test method involving substance-conjugated complement component C1q |
US4849352A (en) * | 1984-10-09 | 1989-07-18 | Sullivan John B | Antibody purification process |
US4753873A (en) * | 1986-02-03 | 1988-06-28 | Cambridge Bioscience Corporation | Peptides for the diagnosis of HTLV-III antibodies, their preparation and use |
EP0694066A4 (de) * | 1993-04-08 | 1997-01-29 | Univ Texas | Modell für die gonokokkeninfektion |
US5691447A (en) * | 1995-03-24 | 1997-11-25 | Tanox Biosystems, Inc. | GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
US5846758A (en) * | 1995-11-30 | 1998-12-08 | His Excellency Ghassan I. Shaker | Method for diagnosing autoimmune diseases |
JP2002515460A (ja) * | 1998-05-20 | 2002-05-28 | イムノメディクス, インコーポレイテッド | 二重特異性抗hlaクラスii不変鎖x抗病原体抗体を使用した治療 |
AU2003212471A1 (en) * | 2002-02-27 | 2003-09-09 | Miragene, Inc. | Improved substrate chemistry for protein immobilization on a rigid support |
US20050054118A1 (en) * | 2002-02-27 | 2005-03-10 | Lebrun Stewart J. | High throughput screening method |
US20070082399A1 (en) * | 2003-07-11 | 2007-04-12 | Tatiana A Egorova-Zachernyuk | Compositions and method for stable isotope labelling of biological compounds |
WO2005025509A2 (en) * | 2003-09-11 | 2005-03-24 | Board Of Regents, The University Of Texas System | Methods and materials for treating autoimmune diseases and conditions |
US7189522B2 (en) | 2005-03-11 | 2007-03-13 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
WO2006098804A2 (en) | 2005-03-11 | 2006-09-21 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
WO2008035527A1 (fr) * | 2006-09-21 | 2008-03-27 | Mmt Co., Ltd. | ANTICORPS MONOCLONAL ANTI-C1q |
CN101516396B (zh) | 2006-09-26 | 2013-10-09 | 传染性疾病研究院 | 包含合成佐剂的疫苗组合物 |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
US20100022916A1 (en) | 2008-07-24 | 2010-01-28 | Javanbakhsh Esfandiari | Method and Apparatus for Collecting and Preparing Biological Samples for Testing |
US8722064B2 (en) | 2009-06-05 | 2014-05-13 | Infectious Disease Research Institute | Synthetic glucopyranosyl lipid adjuvants |
US8603835B2 (en) | 2011-02-10 | 2013-12-10 | Chembio Diagnostic Systems, Inc. | Reduced step dual path immunoassay device and method |
EP3632463A1 (de) | 2011-04-08 | 2020-04-08 | Immune Design Corp. | Immunogene zusammensetzungen und verfahren zur verwendung der zusammensetzungen zur induzierung humoraler und zellulärer immunreaktionen |
PL2811981T3 (pl) | 2012-02-07 | 2019-09-30 | Infectious Disease Research Institute | Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania |
NZ701881A (en) | 2012-05-16 | 2016-10-28 | Immune Design Corp | Vaccines for hsv-2 |
US20160053023A1 (en) | 2013-04-09 | 2016-02-25 | Annexon, Inc. | Methods of treatment for neuromyelitis optica |
EP3711768A1 (de) | 2013-04-18 | 2020-09-23 | Immune Design Corp. | Gla-monotherapie zur verwendung in der krebsbehandlung |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
MX2015017341A (es) | 2013-07-09 | 2016-07-06 | Anexxon Inc | Anticuerpos anti-factor del complemento c1q y uso de los mismos. |
EP3915579A1 (de) | 2013-12-31 | 2021-12-01 | Infectious Disease Research Institute | Impfstoffformulierungen mit einzelphiole |
CN106574223B (zh) | 2014-04-02 | 2019-11-01 | 生化诊断系统公司 | 利用俘获缀合物的免疫测定 |
US20160116466A1 (en) | 2014-10-27 | 2016-04-28 | Chembio Diagnostic Systems, Inc. | Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses |
JP6951246B2 (ja) | 2014-11-05 | 2021-10-20 | アネクソン,インコーポレーテッド | ヒト化抗補体因子C1q抗体及びその使用 |
SG11201803703UA (en) | 2015-11-24 | 2018-06-28 | Annexon Inc | Anti-complement factor c1q fab fragments and uses thereof |
IL298227B1 (en) | 2016-06-01 | 2024-05-01 | Access To Advanced Health Inst | Nanoalum particles containing a fixing factor |
CN109991405B (zh) * | 2017-12-29 | 2023-01-24 | 上海索昕生物科技有限公司 | 一种免疫检测试剂盒及其应用 |
MX2021014363A (es) | 2019-05-25 | 2022-02-21 | Infectious Disease Res Inst | Composicion y metodo para secar por pulverizacion una emulsion de vacuna adyuvante. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4138213A (en) * | 1974-05-20 | 1979-02-06 | Technicon Instruments Corporation | Agglutination immunoassay of immune complex with RF or Clq |
GB1508132A (en) * | 1974-05-20 | 1978-04-19 | Technicon Instr | Analysis of biological fluids |
GB1590524A (en) * | 1976-11-24 | 1981-06-03 | Nat Res Dev | Assay of immune complexes |
US4210622A (en) * | 1977-09-07 | 1980-07-01 | National Research Development Corporation | Kit for assay of immune complexes |
AU6786781A (en) * | 1980-02-22 | 1981-09-11 | Scripps Clinic & Research Foundation | The solid phase anti-c3 assay for detection of immune complexes |
AU8991582A (en) * | 1981-09-18 | 1983-04-08 | Georgetown University | Monoclonal antibody detection system |
AU570213B2 (en) * | 1982-08-12 | 1988-03-10 | Kanegafuchi Chemical Industry Co. Ltd. | Biospecific polymer with biocompatible terpolymer support |
US4595654A (en) * | 1983-11-07 | 1986-06-17 | Immunomedics Inc. | Method for detecting immune complexes in serum |
-
1983
- 1983-11-07 US US06/549,105 patent/US4595654A/en not_active Expired - Lifetime
-
1984
- 1984-11-06 EP EP84904266A patent/EP0161306B1/de not_active Expired - Lifetime
- 1984-11-06 AT AT84904266T patent/ATE66531T1/de not_active IP Right Cessation
- 1984-11-06 WO PCT/US1984/001803 patent/WO1985002261A1/en active IP Right Grant
- 1984-11-06 JP JP59504118A patent/JPH0731195B2/ja not_active Expired - Lifetime
- 1984-11-06 IL IL73437A patent/IL73437A/xx not_active IP Right Cessation
- 1984-11-06 DE DE8484904266T patent/DE3484957D1/de not_active Expired - Fee Related
- 1984-11-06 AU AU36153/84A patent/AU575362B2/en not_active Ceased
- 1984-11-06 CA CA000467117A patent/CA1247539A/en not_active Expired
- 1984-11-07 IT IT23468/84A patent/IT1177121B/it active
-
1985
- 1985-07-04 NO NO852705A patent/NO852705L/no unknown
- 1985-07-05 DK DK309285A patent/DK309285D0/da not_active Application Discontinuation
-
1993
- 1993-04-20 JP JP5116318A patent/JPH0739440B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL73437A0 (en) | 1985-02-28 |
EP0161306A1 (de) | 1985-11-21 |
AU3615384A (en) | 1985-06-03 |
JPH06105699A (ja) | 1994-04-19 |
IT8423468A1 (it) | 1986-05-07 |
JPH0739440B2 (ja) | 1995-05-01 |
EP0161306A4 (de) | 1987-04-14 |
NO852705L (no) | 1985-08-21 |
CA1247539A (en) | 1988-12-28 |
AU575362B2 (en) | 1988-07-28 |
DK309285A (da) | 1985-07-05 |
IL73437A (en) | 1992-06-21 |
WO1985002261A1 (en) | 1985-05-23 |
DK309285D0 (da) | 1985-07-05 |
JPS61500315A (ja) | 1986-02-27 |
US4595654A (en) | 1986-06-17 |
IT1177121B (it) | 1987-08-26 |
IT8423468A0 (it) | 1984-11-07 |
EP0161306B1 (de) | 1991-08-21 |
JPH0731195B2 (ja) | 1995-04-10 |
DE3484957D1 (de) | 1991-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE66531T1 (de) | Verfahren zum nachweis von immunkomplexen im serum. | |
DK158284D0 (da) | Monoklonale antistoffer afledt af tvaerbundne fibrinderivater samt analysemetode til bestemmelse af disse derivater | |
ES8206856A1 (es) | Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica | |
ES445768A1 (es) | Metodo de preparacion de un reactivo en fase solida para usoen el radio inmunoensayo de antigenos y anticuerpos y de realizacon del radio inmunoensayo. | |
DE2965570D1 (en) | Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination | |
JPS5516290A (en) | Purified antigen for testing against neisseria gonorrhoeae antibody | |
ATE48037T1 (de) | Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii. | |
DE3069404D1 (en) | Radioimmunoassay of migration inhibitory factor | |
ZA754230B (en) | Radioimmune assay method for detection of conorrhea antibodies | |
ATE67315T1 (de) | Verfahren zur durchfuehrung von immunfluoreszenztesten. | |
ATE42836T1 (de) | Verfahren und reagenz zur quantitativen bestimmung von freiem thyroxin in plasma, serum oder vollblut. | |
JPS5543498A (en) | Method of detecting and determining complement fixation antibody | |
MY103022A (en) | Monoclonal antibodies recognizing l-thyroxine | |
ATE79475T1 (de) | Verfahren zur bestimmung von immunoglobulin-aprotease. | |
EP0315447A3 (de) | Verfahren zur immunologischen Bestimmung von humanem Protein S sowie Reagens und Kit dafür | |
ATE114052T1 (de) | Immunoassay zur bestimmung der bindungsspezifität eines monoklonalen antikörpers. | |
ES8401261A1 (es) | Soportes de materia plastica revestidos de un segundo anticuerpo. | |
DK414386A (da) | Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse | |
ATE41242T1 (de) | Verfahren zur bestimmung einer immunologisch bindefaehigen substanz. | |
ATE14161T1 (de) | Verfahren zur bestimmung von immunkomplexen. | |
EP0248147A3 (de) | Verfahren zur Bestimmung der Anwesenheit von Krebszellen | |
SE8705137D0 (sv) | Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method | |
GB1549921A (en) | Process for quantitative determination of antigen or antibody | |
DE3478346D1 (en) | Method for assaying basic fetoprotein and reagent therefor | |
GB1528312A (en) | System for use in a radioimmunoassay for human thyrotropic hormone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |